Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Renal Failure
|
October 21, 2024
Development and validation of a chronic kidney disease progression model using patient-level simulations
Mafalda Ramos, Laetitia Gerlier, Anastasia Uster, et al.
Journal of Diabetes and Its Complications
|
October 18, 2023
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of risk
Robert Weingold, Bernard Zinman, Michaela Mattheus, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2015
Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?
Susanne Tholen, Christoph Schmaderer, Stefan Chmielewski, et al.
Diabetes, Obesity & Metabolism
|
September 24, 2021
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial
João Pedro Ferreira, Silvio E Inzucchi, Michaela Mattheus, et al.
Kidney & Blood Pressure Research
|
March 10, 2016
Comparison of Peritoneal Low-Molecular-Weight-Protein-Removal in CCPD and CAPD Patients Based on C-Terminal Agrin Fragment Clearance
Dominik Steubl, Marcel Roos, Stefan Hettwer, et al.
Abdominal Imaging
|
March 26, 2015
Comparison of a pocket-size ultrasound device with a premium ultrasound machine: diagnostic value and time required in bedside ultrasound examination
Konrad Friedrich Stock, Bettina Klein, Dominik Steubl, et al.
Plos One
|
July 6, 2016
The C-Terminal Fragment of Agrin (CAF), a Novel Marker of Renal Function, Is Filtered by the Kidney and Reabsorbed by the Proximal Tubule
Arezoo Daryadel, Monika Haubitz, Marta Figueiredo, et al.
Kidney Medicine
|
February 29, 2024
Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial
Samy Hadjadj, Mark E Cooper, Dominik Steubl, et al.
Plos One
|
March 1, 2018
Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells
Fabian Schlott, Dominik Steubl, Stefanie Ameres, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
October 30, 2016
Serum uromodulin predicts graft failure in renal transplant recipients
Dominik Steubl, Matthias Block, Victor Herbst, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Renal Failure
|
October 21, 2024
Development and validation of a chronic kidney disease progression model using patient-level simulations
Mafalda Ramos, Laetitia Gerlier, Anastasia Uster, et al.
Journal of Diabetes and Its Complications
|
October 18, 2023
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of risk
Robert Weingold, Bernard Zinman, Michaela Mattheus, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2015
Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?
Susanne Tholen, Christoph Schmaderer, Stefan Chmielewski, et al.
Diabetes, Obesity & Metabolism
|
September 24, 2021
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial
João Pedro Ferreira, Silvio E Inzucchi, Michaela Mattheus, et al.
Kidney & Blood Pressure Research
|
March 10, 2016
Comparison of Peritoneal Low-Molecular-Weight-Protein-Removal in CCPD and CAPD Patients Based on C-Terminal Agrin Fragment Clearance
Dominik Steubl, Marcel Roos, Stefan Hettwer, et al.
Abdominal Imaging
|
March 26, 2015
Comparison of a pocket-size ultrasound device with a premium ultrasound machine: diagnostic value and time required in bedside ultrasound examination
Konrad Friedrich Stock, Bettina Klein, Dominik Steubl, et al.
Plos One
|
July 6, 2016
The C-Terminal Fragment of Agrin (CAF), a Novel Marker of Renal Function, Is Filtered by the Kidney and Reabsorbed by the Proximal Tubule
Arezoo Daryadel, Monika Haubitz, Marta Figueiredo, et al.
Kidney Medicine
|
February 29, 2024
Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial
Samy Hadjadj, Mark E Cooper, Dominik Steubl, et al.
Plos One
|
March 1, 2018
Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells
Fabian Schlott, Dominik Steubl, Stefanie Ameres, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
October 30, 2016
Serum uromodulin predicts graft failure in renal transplant recipients
Dominik Steubl, Matthias Block, Victor Herbst, et al.
Page
of 8